Evidence map›Paper›PMID 25553375›Full record

ReviewFrontiers in bioscience (Elite edition)2015

Current strategies and challenges in engineering a bioartificial kidney.

Steven Kim, William H Fissell, David H Humes, Shuvo Roy

Abstract readReview
In one paragraph

Review in Frontiers in bioscience (Elite edition), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Contemporary Perspectives on Chronic Renal Disorders.Chronic diseases and translational medicine · 2025
    Review
  2. Article
  3. Cell and gene therapy for kidney disease.Nature reviews. Nephrology · 2023
    Review
  4. Article
  5. Advances in hemodialysis therapy.Faculty reviews · 2023
    Review
  6. Powering Implantable and Ingestible Electronics.Advanced functional materials · 2021
    Article
  7. Mechanical characterization of native and sugar-modified decellularized kidneys.Journal of the mechanical behavior of biomedical materials · 2021
    Article
  8. Role of Artificial Intelligence in Kidney Disease.International journal of medical sciences · 2020
    Review
  9. Review
  10. Article
  11. Engineering molecular imaging strategies for regenerative medicine.Bioengineering & translational medicine · 2018
    Review
  12. Article
  13. Article
  14. Bioartificial Kidneys.Current stem cell reports · 2017
    Article
  15. Article
  16. Article
  17. Chronic Hemodialysis Therapy in the West.Kidney diseases (Basel, Switzerland) · 2015
    Review
  18. Review
  19. Article
  20. The future of the artificial kidney.Indian journal of urology : IJU : journal of the Urological Society of India
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Steven KimDivision of Nephrology, Department of Medicine, University of California, San Francisco.
William H FissellDivision of Nephrology, Department of Medicine, University of California, San Francisco.
David H HumesDivision of Nephrology, Department of Medicine, University of California, San Francisco.
Shuvo RoyDivision of Nephrology, Department of Medicine, University of California, San Francisco.

Funding

Biocompatibility of Implantable Renal Replacement DevicesR01EB014315 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROY, SHUVO · 2012 to 2015
$2.3M
NIBIB NIH HHS R01 EB014315
6 · The paper itself

Abstract

Renal replacement therapy was an early pioneer in both extra-corporeal organ replacement and whole organ transplantation. Today, the success of this pioneering work is directly demonstrated in the millions of patients worldwide successfully treated with dialysis and kidney transplantation. However, there remain significant shortcomings to current treatment modalities that limit clinical outcomes and quality of life. To address these problems, researchers have turned to using cell-based therapies for the development of a bioartificial kidney. These approaches aim to recapitulate the numerous functions of the healthy kidney including solute clearance, fluid homeostasis and metabolic and endocrine functions. This review will examine the state-of-the-art in kidney bioengineering by evaluating the various techniques currently being utilized to create a bioartificial kidney. These promising new technologies, however, still need to address key issues that may limit the widespread adoption of cell therapy including cell sourcing, organ scaffolding, and immune response. Additionally, while these new methods have shown success in animal models, it remains to be seen whether these techniques can be successfully adapted for clinical treatment in humans.

Indexed as

Bioartificial OrgansBioengineeringKidneyKidneys, ArtificialAnimalsCell TransplantationHumansKidney Failure, ChronicOrganogenesisTissue Scaffolds

Identifiers

PMID25553375
PMCPMC4383659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.